Minutes of the Extraordinary General Meeting
At the Extraordinary General Meeting of ORIGIO A/S held at 13:00 CET on August 10, 2012 at Plesner Law Firm, Amerika Plads 37, 2100 Copenhagen, Denmark, the following business was transacted:
- Election of new members of the Board of Directors.
- Authorisation given to the Board of Directors to apply for delisting of ORIGIO A/S from Oslo Stock Exchange.
- Authorisation to the Chairman of the Meeting.
Download here the Minutes from the Extraordinary General Meeting.
For further information, please contact:
Jesper Funding Andersen, CEO: +45 4073 0963
or email: email@example.com
Julie Quist, Director IR & BD: +45 2780 4942
or email: firstname.lastname@example.org
About ORIGIO a/s
ORIGIO a/s is a world leader in Assisted Reproductive Technology (ART) solutions. Through research and innovation, ORIGIO aims to provide the best products to ART professionals to help the #1 dream of every infertile couple come true. ORIGIO currently comprises the five product families, MediCult Media, Humagen Pipets, MidAtlantic Devices, ORIGIO ScanLab Equipment and Artworks Solutions that cater for the broadest range of ART requirements. The medtech company ORIGIO, which is headquartered in Måløv, Denmark, and has subsidiaries in 12 countries, is listed on the Oslo Stock Exchange under the symbol, ORO. For further information, please visit www.origio.com.
About Cooper Companies, Inc.
The Cooper Companies, Inc. is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,000 employees with products sold in over 100 countries. For more information, please visit
Certain statements in this announcement contain forward-looking statements that involve a number of risks and uncertainties. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. There can be no assurance that any of the forward-looking statements identified in this announcement will occur. Conducting studies for investigational products are subject to risks and uncertainties. There can be no assurance that planned studies can be initiated, that planned or ongoing studies can be successfully concluded or concluded in accordance with ORIGIO’s anticipated schedule. These factors, and other factors including, but not limited to, those described in ORIGIO’s most recent annual report, could cause future results to differ materially from the expectations expressed in this announcement. The forward-looking statements contained in this announcement may become outdated over time. ORIGIO does not assume any responsibility for updating any forward-looking statements.